General Information of Drug (ID: DMOVMGA)

Drug Name
GSK4527226 Drug Info
Synonyms AL101
Indication
Disease Entry ICD 11 Status REF
Neurodegenerative disorder 8A20-8A23 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMOVMGA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Sortilin (SORT1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AL001 DM7YBGH Frontotemporal dementia 6D83 Phase 3 [2]
GSK4527223 DMXLD07 Frontotemporal dementia 6D83 Phase 3 [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sortilin (SORT1) TTRX9AV SORT_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of GlaxoSmithKline
2 Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. J Transl Med. 2023 Jun 15;21(1):387.